# Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project

> **NCT05456360** · PHASE2,PHASE3 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 89 (actual)

## Conditions studied

- Sleep

## Interventions

- **DEVICE:** ViSi Mobile device
- **DRUG:** Sleep enhancement intervention

## Key facts

- **NCT ID:** NCT05456360
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 89 (ACTUAL)
- **Why stopped:** Poor accrual and poor patient engagement with survey completion
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05456360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05456360, "Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05456360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*